SCHEMBL16152079

SCHEMBL16152079

Cn1nccc1Oc1cc(Sc2ccccc2)cnc1Nc1nc(C(O)CO)cs1

nearest known ligand 0.54

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ GCK P35557 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16152078 0.93 GCK (0.48) GCK
SCHEMBL16152084 0.90 GCK (0.45) GCK
SCHEMBL16152082 0.89 GCK (0.45) GCK
SCHEMBL16152071 0.88 GCK (0.46) GCK
SCHEMBL16152072 0.88 GCK (0.53) GCK
SCHEMBL10297670 0.88 GCK (0.56) GCK
SCHEMBL16152083 0.87 GCK (0.45) GCK
SCHEMBL16152067 0.84 GCK (0.38) GCK
SCHEMBL10297602 0.83 GCK (0.56) GCK
SCHEMBL10297626 0.82 GCK (0.54) GCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8853409-B2 Pyridin-2yl-amino-1, 2, 4-thiadiazole derivatives as glucokinase activators for the treatment of diabetes mellitus ARRAY BIOPHARMA INC. (US) 2014-10-07 — — US disclosed
Send feedback